{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:35:24Z","timestamp":1793115324388,"version":"4.5.0"},"reference-count":96,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Antiplatelet drugs are a pillar in the treatment strategy to prevent ischemic events in patients with cardiovascular disease. However, the action of existing therapies is nonuniform, and the causative mechanism for this variability remains poorly understood. The differences in the microRNA (miRNA) profiles among individuals have been suggested to impact platelet reactivity and treatment outcomes. In several previous clinical reports, miR-150 has been associated with platelet function variability and cardiovascular events. Therefore, we initiated our analysis by examining the mechanistic role of miR-150 in platelet function. We employed transgenic zebrafish larvae that were designed to specifically increase miR-150 expression in thrombocytes. Laser-induced caudal vein injury in these animals led to the formation of a smaller thrombus and decreased thrombocyte accumulation. RNA sequencing of miR-150\u2013overexpressing thrombocytes identified a downregulated transcript that encoded microtubule-associated serine\/threonine kinase-like (mastl), a key regulator of P2Y12 receptor downstream signaling. Overnight treatment of the transgenic fish with clopidogrel, a P2Y12 inhibitor, showed decreased thrombus formation in the control but not in the miR-150\u2013overexpressing animals. This phenotype was reversed by overexpressing mastl. Next, we used a Vasodilator-Stimulated Phosphoprotein (VASP) phosphorylation assay to show that MASTL deficiency partially protects human platelets from P2Y12 inhibition. Finally, using miRNA:mRNA interaction predictors and experimental assays, we identified MASTL-targeting miRNAs in humans, specifically miR-17-5p and miR-106a-5p, which were significantly upregulated in a population of patients who were clopidogrel resistant. Our studies therefore support a model in which miR-150 in zebrafish and miR-17-5p or miR-106a-5p in humans modulate MASTL expression, which, in turn, alters VASP phosphorylation and platelet sensitivity to P2Y12 inhibition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019008","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:50:43Z","timestamp":1784634643000},"page":"7125-7138","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["The zebrafish model tackles anti-P2Y12 variability in humans: a translational approach"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5139-9635","authenticated-orcid":false,"given":"Paulina","family":"Ciepla","sequence":"first","affiliation":[{"name":"1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2830-4260","authenticated-orcid":false,"given":"Richard J.","family":"Fish","sequence":"additional","affiliation":[{"name":"2Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Nolli","sequence":"additional","affiliation":[{"name":"1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Dunoyer-Geindre","sequence":"additional","affiliation":[{"name":"1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8858-6311","authenticated-orcid":false,"given":"Julia","family":"Charlon-Gay","sequence":"additional","affiliation":[{"name":"1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7528-7363","authenticated-orcid":false,"given":"Jean-Luc","family":"Reny","sequence":"additional","affiliation":[{"name":"1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland"},{"name":"3Division of General Internal Medicine, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9351-4195","authenticated-orcid":false,"given":"Marguerite","family":"Neerman-Arbez","sequence":"additional","affiliation":[{"name":"2Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1546-0774","authenticated-orcid":false,"given":"Pierre","family":"Fontana","sequence":"additional","affiliation":[{"name":"1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland"},{"name":"4Division of Angiology and Haemostasis, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"issue":"12","key":"2026102711124758800_bib1","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1016\/j.jtha.2023.09.013","article-title":"Antiplatelet strategies: past, present, and future","volume":"21","author":"Stanger","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"22","key":"2026102711124758800_bib2","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.jcin.2024.08.027","article-title":"International consensus statement on platelet function and genetic testing in percutaneous coronary intervention: 2024 update","volume":"17","author":"Angiolillo","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"2026102711124758800_bib3","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.jcin.2019.07.034","article-title":"Platelet function testing or genotyping: which should we trust?","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"2026102711124758800_bib4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"2026102711124758800_bib5","doi-asserted-by":"crossref","first-page":"e50746","DOI":"10.1371\/journal.pone.0050746","article-title":"The repertoire and features of human platelet microRNAs","volume":"7","author":"Pl\u00e9","year":"2012","journal-title":"PLOS ONE"},{"issue":"12","key":"2026102711124758800_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrcardio.2015.101","article-title":"MicroRNAs in platelet function and cardiovascular disease","volume":"12","author":"McManus","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"2026102711124758800_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/a-1478-2105","article-title":"Do miRNAs have a role in platelet function regulation?","volume":"41","author":"Garcia","year":"2021","journal-title":"Hamostaseologie"},{"issue":"19","key":"2026102711124758800_bib8","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1182\/blood-2010-09-299719","article-title":"Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity","volume":"117","author":"Nagalla","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2026102711124758800_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/09537104.2022.2042236","article-title":"Circulating microRNAs as biomarkers and mediators of platelet activation","volume":"33","author":"Gutmann","year":"2022","journal-title":"Platelets"},{"issue":"2","key":"2026102711124758800_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1676802","article-title":"Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells","volume":"119","author":"Garcia","year":"2019","journal-title":"Thromb Haemost"},{"issue":"6","key":"2026102711124758800_bib11","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/09537104.2020.1775804","article-title":"MicroRNA-126 is a regulator of platelet-supported thrombin generation","volume":"31","author":"Zapilko","year":"2020","journal-title":"Platelets"},{"issue":"9","key":"2026102711124758800_bib12","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1055\/a-1497-9649","article-title":"miR-204-5p and platelet function regulation: insight into a mechanism mediated by CDC42 and GPIIbIIIa","volume":"121","author":"Garcia","year":"2021","journal-title":"Thromb Haemost"},{"issue":"9","key":"2026102711124758800_bib13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nsmb.1651","article-title":"Existence of a microRNA pathway in anucleate platelets","volume":"16","author":"Landry","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"2026102711124758800_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1538-7836.2009.03700.x","article-title":"VAMP8\/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA","volume":"8","author":"Kondkar","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2026102711124758800_bib15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.115.306823","article-title":"Animal models of thrombosis from zebrafish to nonhuman primates","volume":"118","author":"Jagadeeswaran","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"2026102711124758800_bib16","first-page":"857058","article-title":"Zebrafish thrombocytes: functions and origins","volume":"2012","author":"Khandekar","year":"2012","journal-title":"Adv Hematol"},{"issue":"4","key":"2026102711124758800_bib17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jtha.2023.12.025","article-title":"Composition of thrombi in zebrafish: similarities and distinctions with mammals","volume":"22","author":"Griffin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"2026102711124758800_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-12-387036-0.00009-8","volume-title":"Methods in Cell Biology","author":"Jagadeeswaran","year":"2011","edition":"1st ed"},{"issue":"5732","key":"2026102711124758800_bib19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.1114519","article-title":"MicroRNA expression in zebrafish embryonic development","volume":"309","author":"Wienholds","year":"2005","journal-title":"Science"},{"issue":"1","key":"2026102711124758800_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1182\/blood-2014-03-561027","article-title":"Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function","volume":"124","author":"Liu","year":"2014","journal-title":"Blood"},{"issue":"11","key":"2026102711124758800_bib21","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/bloodadvances.2018029066","article-title":"Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis","volume":"3","author":"Weyand","year":"2019","journal-title":"Blood Adv"},{"issue":"9","key":"2026102711124758800_bib22","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1111\/jth.15365","article-title":"Identification of zebrafish ortholog for human coagulation factor IX and its age-dependent expression","volume":"19","author":"Iyer","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026102711124758800_bib23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/bloodadvances.2024013237","article-title":"Loss of protein C vs protein S results in discrepant thrombotic phenotypes","volume":"9","author":"Ku","year":"2025","journal-title":"Blood Adv"},{"issue":"12","key":"2026102711124758800_bib24","doi-asserted-by":"crossref","first-page":"e52622","DOI":"10.1371\/journal.pone.0052622","article-title":"G6f-like is an ITAM-containing collagen receptor in thrombocytes","volume":"7","author":"Hughes","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"2026102711124758800_bib25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2019.237396","article-title":"Histone-induced thrombotic thrombocytopenic purpura in adamts13\u2212\/\u2212 zebrafish depends on von Willebrand factor","volume":"105","author":"Liang","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"2026102711124758800_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.3324\/haematol.2021.278893","article-title":"Establishment of a Bernard-Soulier syndrome model in zebrafish","volume":"107","author":"Lin","year":"2022","journal-title":"Haematologica"},{"issue":"4","key":"2026102711124758800_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jth.14391","article-title":"Loss of fibrinogen in zebrafish results in an asymptomatic embryonic hemostatic defect and synthetic lethality with thrombocytopenia","volume":"17","author":"Hu","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"21","key":"2026102711124758800_bib28","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1182\/bloodadvances.2020001472","article-title":"A genetic modifier of venous thrombosis in zebrafish reveals a functional role for fibrinogen A\u03b1E in early hemostasis","volume":"4","author":"Freire","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2026102711124758800_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/ijms22020655","article-title":"Venous thrombosis and thrombocyte activity in zebrafish models of quantitative and qualitative fibrinogen disorders","volume":"22","author":"Fish","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2026102711124758800_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00439-016-1642-1","article-title":"New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach","volume":"135","author":"Zufferey","year":"2016","journal-title":"Hum Genet"},{"issue":"8","key":"2026102711124758800_bib31","doi-asserted-by":"crossref","first-page":"e13149","DOI":"10.1111\/eci.13149","article-title":"Course of platelet miRNAs after cessation of P2Y12 antagonists","volume":"49","author":"J\u00e4ger","year":"2019","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"2026102711124758800_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/jpm11050323","article-title":"An ex vivo and in silico study providing insights into the interplay of circulating miRNAs level, platelet reactivity and thrombin generation: looking beyond traditional pharmacogenetics","volume":"11","author":"Garcia","year":"2021","journal-title":"J Pers Med"},{"key":"2026102711124758800_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.thromres.2022.01.026","article-title":"Association of whole blood microRNA expression with platelet function and turnover in patients with coronary artery disease","volume":"211","author":"Pedersen","year":"2022","journal-title":"Thromb Res"},{"issue":"3","key":"2026102711124758800_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-0043-1776305","article-title":"Platelet function and maturity and related microRNA expression in whole blood in patients with ST-segment elevation myocardial infarction","volume":"124","author":"Pedersen","year":"2024","journal-title":"Thromb Haemost"},{"issue":"10","key":"2026102711124758800_bib35","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/molbev\/msn165","article-title":"c-Myb is an evolutionary conserved miR-150 target and miR-150\/c-Myb interaction is important for embryonic development","volume":"25","author":"Lin","year":"2008","journal-title":"Mol Biol Evol"},{"key":"2026102711124758800_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-60327-019-9_3","volume-title":"Transgenesis Techniques: Principles and Protocols","author":"Suster","year":"2009","edition":"3rd ed"},{"issue":"12","key":"2026102711124758800_bib37","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1538-7836.2010.04063.x","article-title":"Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study","volume":"8","author":"Fontana","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"25","key":"2026102711124758800_bib38","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1161\/CIRCULATIONAHA.111.085464","article-title":"Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the antiplatelet drug resistances and Ischemic events study","volume":"125","author":"Reny","year":"2012","journal-title":"Circulation"},{"issue":"15","key":"2026102711124758800_bib39","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/hrt.2010.220509","article-title":"Variability in on-treatment platelet reactivity explained by CYP2C19\u22172 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting","volume":"97","author":"Bouman","year":"2011","journal-title":"Heart"},{"issue":"22","key":"2026102711124758800_bib40","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jacc.2010.02.031","article-title":"Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement","volume":"55","author":"Hochholzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2026102711124758800_bib41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1160\/TH06-09-0491","article-title":"Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor","volume":"96","author":"Pampuch","year":"2006","journal-title":"Thromb Haemost"},{"issue":"3","key":"2026102711124758800_bib42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","article-title":"Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition of ticlopidine\/clopidogrel effects","volume":"82","author":"Schwarz","year":"1999","journal-title":"Thromb Haemost"},{"issue":"4","key":"2026102711124758800_bib43","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.thromres.2013.12.038","article-title":"MiR-150 enhances the motility of EPCs in vitro and promotes EPCs homing and thrombus resolving in vivo","volume":"133","author":"Wang","year":"2014","journal-title":"Thromb Res"},{"key":"2026102711124758800_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mvr.2018.10.003","article-title":"MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1","volume":"123","author":"Wang","year":"2019","journal-title":"Microvasc Res"},{"issue":"39","key":"2026102711124758800_bib45","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.1073\/pnas.1508426112","article-title":"Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization","volume":"112","author":"Liu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2026102711124758800_bib46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/cns.12525","article-title":"MiR-150 regulates poststroke cerebral angiogenesis via vascular endothelial growth factor in rats","volume":"22","author":"He","year":"2016","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"2026102711124758800_bib47","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1038\/s41598-023-42868-7","article-title":"Role of microRNAs and their downstream target transcription factors in zebrafish thrombopoiesis","volume":"13","author":"Al Qaryoute","year":"2023","journal-title":"Sci Rep"},{"issue":"12","key":"2026102711124758800_bib48","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1182\/blood-2005-01-0179","article-title":"Analysis of thrombocyte development in CD41-GFP transgenic zebrafish","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2026102711124758800_bib49","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1242\/dev.015297","article-title":"CD41+ cmyb+ precursors colonize the zebrafish pronephros by a novel migration route to initiate adult hematopoiesis","volume":"135","author":"Bertrand","year":"2008","journal-title":"Development"},{"issue":"6","key":"2026102711124758800_bib50","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2006.10.015","article-title":"Tracing hematopoietic precursor migration to successive hematopoietic organs during zebrafish development","volume":"25","author":"Murayama","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"2026102711124758800_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"7","key":"2026102711124758800_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of mammalian MicroRNA targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"issue":"10","key":"2026102711124758800_bib53","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1101\/gr.139733.112","article-title":"Extensive alternative polyadenylation during zebrafish development","volume":"22","author":"Ulitsky","year":"2012","journal-title":"Genome Res"},{"issue":"web server issue","key":"2026102711124758800_bib54","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkt393","article-title":"DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows","volume":"41","author":"Paraskevopoulou","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2026102711124758800_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/bioinformatics\/bts043","article-title":"Functional microRNA targets in protein coding sequences","volume":"28","author":"Reczko","year":"2012","journal-title":"Bioinformatics"},{"issue":"4","key":"2026102711124758800_bib56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/zeb.2016.1263","article-title":"A zebrafish thrombosis model for assessing antithrombotic drugs","volume":"13","author":"Zhu","year":"2016","journal-title":"Zebrafish"},{"key":"2026102711124758800_bib57","doi-asserted-by":"crossref","first-page":"173292","DOI":"10.1016\/j.ejphar.2020.173292","article-title":"Ponatinib-induced ischemic stroke in larval zebrafish for drug screening","volume":"889","author":"Zhu","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2026102711124758800_bib58","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/infdis\/jiz110","article-title":"Thrombocyte inhibition restores protective immunity to mycobacterial infection in zebrafish","volume":"220","author":"Hortle","year":"2019","journal-title":"J Infect Dis"},{"issue":"4","key":"2026102711124758800_bib59","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1999.01763.x","article-title":"Identification and characterization of zebrafish thrombocytes","volume":"107","author":"Jagadeeswaran","year":"1999","journal-title":"Br J Haematol"},{"issue":"11","key":"2026102711124758800_bib60","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1371\/journal.pgen.0030200","article-title":"Mutations in drosophila greatwall\/scant reveal its roles in mitosis and meiosis and interdependence with polo kinase","volume":"3","author":"Archambault","year":"2007","journal-title":"PLoS Genet"},{"issue":"6011","key":"2026102711124758800_bib61","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1197048","article-title":"The substrate of greatwall kinase, Arpp19, controls mitosis by inhibiting protein phosphatase 2A","volume":"330","author":"Gharbi-Ayachi","year":"2010","journal-title":"Science"},{"issue":"18","key":"2026102711124758800_bib62","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1182\/blood-2015-09-670208","article-title":"Aryl hydrocarbon receptor\u2013dependent enrichment of a megakaryocytic precursor with a high potential to produce proplatelets","volume":"127","author":"Strassel","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2026102711124758800_bib63","doi-asserted-by":"crossref","first-page":"e201906204","DOI":"10.1083\/jcb.201906204","article-title":"MASTL promotes cell contractility and motility through kinase-independent signaling","volume":"219","author":"Taskinen","year":"2020","journal-title":"J Cell Biol"},{"issue":"3","key":"2026102711124758800_bib64","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0006-2952(92)90445-O","article-title":"Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel","volume":"44","author":"Savi","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"2026102711124758800_bib65","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"issue":"6472","key":"2026102711124758800_bib66","doi-asserted-by":"crossref","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"issue":"5","key":"2026102711124758800_bib67","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat Genet"},{"issue":"W1","key":"2026102711124758800_bib68","doi-asserted-by":"crossref","first-page":"W148","DOI":"10.1093\/nar\/gkad283","article-title":"DIANA-microT 2023: including predicted targets of virally encoded miRNAs","volume":"51","author":"Tastsoglou","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2026102711124758800_bib69","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"2026102711124758800_bib70","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1182\/blood-2013-12-544692","article-title":"Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics","volume":"123","author":"Simon","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2026102711124758800_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-14-1","article-title":"The complex transcriptional landscape of the anucleate human platelet","volume":"14","author":"Bray","year":"2013","journal-title":"BMC Genomics"},{"issue":"2","key":"2026102711124758800_bib72","doi-asserted-by":"crossref","first-page":"e00751","DOI":"10.1002\/prp2.751","article-title":"The expression profile of platelet-derived miRNA in coronary artery disease patients with clopidogrel resistance","volume":"9","author":"Lin","year":"2021","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"2026102711124758800_bib73","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41401-018-0041-7","article-title":"Plasma miR-142 predicts major adverse cardiovascular events as an intermediate biomarker of dual antiplatelet therapy","volume":"40","author":"Tang","year":"2019","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2026102711124758800_bib74","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymeth.2007.09.005","article-title":"Experimental validation of miRNA targets","volume":"44","author":"Kuhn","year":"2008","journal-title":"Methods"},{"issue":"2","key":"2026102711124758800_bib75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40139-015-0081-3","article-title":"Modeling disorders of blood coagulation in the zebrafish","volume":"3","author":"Kretz","year":"2015","journal-title":"Curr Pathobiol Rep"},{"issue":"6","key":"2026102711124758800_bib76","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1538-7836.2010.03815.x","article-title":"Hemostasis in Danio rerio: is the zebrafish a useful model for platelet research?","volume":"8","author":"Lang","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2026102711124758800_bib77","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/leu.2010.280","article-title":"Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb","volume":"25","author":"Grabher","year":"2011","journal-title":"Leukemia"},{"issue":"12","key":"2026102711124758800_bib78","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1172\/JCI121876","article-title":"Thrombocytopenia-associated mutations in Ser\/Thr kinase MASTL deregulate actin cytoskeletal dynamics in platelets","volume":"128","author":"Hurtado","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"2026102711124758800_bib79","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000071812","article-title":"FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10","volume":"55","author":"Gandhi","year":"2003","journal-title":"Hum Hered"},{"issue":"8","key":"2026102711124758800_bib80","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.exphem.2009.05.005","article-title":"In vivo inactivation of MASTL kinase results in thrombocytopenia","volume":"37","author":"Johnson","year":"2009","journal-title":"Exp Hematol"},{"issue":"20","key":"2026102711124758800_bib81","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/1873-3468.13595","article-title":"Getting out of mitosis: spatial and temporal control of mitotic exit and cytokinesis by PP1 and PP2A","volume":"593","author":"Holder","year":"2019","journal-title":"FEBS Lett"},{"issue":"8","key":"2026102711124758800_bib82","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrm3149","article-title":"Phosphatases: providing safe passage through mitotic exit","volume":"12","author":"Wurzenberger","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2026102711124758800_bib83","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/cells9020472","article-title":"The cell cycle checkpoint system MAST(L)-ENSA\/ARPP19-PP2A is targeted by cAMP\/PKA and cGMP\/PKG in anucleate human platelets","volume":"9","author":"Kumm","year":"2020","journal-title":"Cells"},{"issue":"19","key":"2026102711124758800_bib84","doi-asserted-by":"crossref","first-page":"12862","DOI":"10.1074\/jbc.M708804200","article-title":"Protein phosphatase 2A negatively regulates integrin \u03b1IIb\u03b23 signaling","volume":"283","author":"Gushiken","year":"2008","journal-title":"J Biol Chem"},{"issue":"23","key":"2026102711124758800_bib85","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.3390\/ijms21238939","article-title":"The serine\/threonine protein phosphatase 2A (PP2A) regulates Syk activity in human platelets","volume":"21","author":"Makhoul","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2026102711124758800_bib86","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-5793(95)00817-S","article-title":"Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human platelets","volume":"370","author":"Abel","year":"1995","journal-title":"FEBS Lett"},{"issue":"5","key":"2026102711124758800_bib87","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bcp.2011.05.022","article-title":"Differential dephosphorylation of the Protein Kinase C-zeta (PKC\u03b6) in an integrin \u03b1IIb\u03b23-dependent manner in platelets","volume":"82","author":"Mayanglambam","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"pt 2","key":"2026102711124758800_bib88","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1042\/bj3070439","article-title":"Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1\/2 A inhibitors okadaic acid and calyculin A","volume":"307","author":"Yano","year":"1995","journal-title":"Biochem J"},{"issue":"6011","key":"2026102711124758800_bib89","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1195689","article-title":"Greatwall phosphorylates an inhibitor of protein phosphatase 2\u0391 that is essential for mitosis","volume":"330","author":"Mochida","year":"2010","journal-title":"Science"},{"issue":"1","key":"2026102711124758800_bib90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1994.00021.x","article-title":"Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition","volume":"225","author":"Horstrup","year":"1994","journal-title":"Eur J Biochem"},{"issue":"3","key":"2026102711124758800_bib91","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrcardio.2017.206","article-title":"Current and future antiplatelet therapies: emphasis on preserving haemostasis","volume":"15","author":"McFadyen","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"2026102711124758800_bib92","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","article-title":"Current concepts and novel targets for antiplatelet therapy","volume":"20","author":"Gawaz","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"2026102711124758800_bib93","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.ATV.19.8.2007","article-title":"Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel","volume":"19","author":"Geiger","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2026102711124758800_bib94","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/bloodadvances.2024015290","article-title":"MicroRNA-223-3p is a determinant of platelet procoagulant activity","volume":"10","author":"Charlon-Gay","year":"2026","journal-title":"Blood Adv"},{"issue":"6","key":"2026102711124758800_bib95","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/jth.14776","article-title":"Contribution of exome sequencing to the identification of genes involved in the response to clopidogrel in cardiovascular patients","volume":"18","author":"Fontana","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2026102711124758800_bib96","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/cpt.1911","article-title":"Genomewide association study of platelet reactivity and cardiovascular response in patients treated with clopidogrel: a study by the International Clopidogrel Pharmacogenomics Consortium","volume":"108","author":"Verma","year":"2020","journal-title":"Clin Pharmacol Ther"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/20\/7125\/2595820\/blooda_adv-2025-019008-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/20\/7125\/2595820\/blooda_adv-2025-019008-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:13:03Z","timestamp":1793113983000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/20\/7125\/569772\/The-zebrafish-model-tackles-anti-P2Y12-variability"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":96,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019008","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,27]]},"published":{"date-parts":[[2026,10,19]]}}}